Evotec SE (EVOTF)
6.69
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Evotec EPS Diluted (Quarterly) : -0.8034 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.8034 |
| December 31, 2025 | 0.0958 |
| September 30, 2025 | -0.2834 |
| June 30, 2025 | -0.2775 |
| March 31, 2025 | -0.1872 |
| December 31, 2024 | -0.2453 |
| September 30, 2024 | -0.2455 |
| June 30, 2024 | -0.5764 |
| March 31, 2024 | -0.1266 |
| December 31, 2023 | -0.098 |
| September 30, 2023 | -0.2395 |
| June 30, 2023 | -0.0918 |
| March 31, 2023 | -0.0843 |
| December 31, 2022 | -0.157 |
| September 30, 2022 | -0.2693 |
| June 30, 2022 | -0.1683 |
| March 31, 2022 | -0.465 |
| December 31, 2021 | -0.204 |
| September 30, 2021 | 0.962 |
| June 30, 2021 | 0.4403 |
| March 31, 2021 | 0.3869 |
| December 31, 2020 | 0.0019 |
| September 30, 2020 | -0.0109 |
| June 30, 2020 | -0.0716 |
| March 31, 2020 | 0.1246 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.0581 |
| September 30, 2019 | 0.1414 |
| June 30, 2019 | -0.0179 |
| March 31, 2019 | 0.0994 |
| December 31, 2018 | 0.2414 |
| September 30, 2018 | 0.2726 |
| June 30, 2018 | 0.1191 |
| March 31, 2018 | 0.0288 |
| December 31, 2017 | 0.0841 |
| September 30, 2017 | 0.0191 |
| June 30, 2017 | 0.022 |
| March 31, 2017 | 0.0533 |
| December 31, 2016 | 0.1185 |
| September 30, 2016 | 0.0781 |
| June 30, 2016 | 0.0339 |
| March 31, 2016 | -0.011 |
| December 31, 2015 | 0.0438 |
| September 30, 2015 | -0.0222 |
| June 30, 2015 | 0.1217 |
| March 31, 2015 | -0.0112 |
| December 31, 2014 | 0.0125 |
| September 30, 2014 | -0.0397 |
| June 30, 2014 | -0.0044 |
| March 31, 2014 | -0.0411 |
| December 31, 2013 | -0.2314 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lifecore Biomedical, Inc. | -0.4252 |
| Codexis, Inc. | -0.0959 |
| Quanterix Corp. | -0.3734 |
| Sartorius Stedim Biotech SA | 0.1059 |
| CureVac NV | 1.414 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -142.66M |
| Revenue (Quarterly) | 183.26M |
| Total Expenses (Quarterly) | 325.92M |
| Enterprise Value | 1.122B |
| Gross Profit Margin (Quarterly) | -1.00% |
| Profit Margin (Quarterly) | -77.84% |
| Earnings Yield | -18.96% |
| Normalized Earnings Yield | -13.73 |